Newsroom

Welcome to Blood Cancer United Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Patient Education Webcasts June 8, 2023

Spotlight on Aggressive Non-Hodgkin Lymphomas (NHL)

Research June 8, 2023

Immune-Onc Therapeutics Announces IO-202 Granted Fast Track Designation by FDA for the Treatment of Relapsed or Refractory CMML

PALO ALTO, CA, June 7, 2023 – Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage oncology company dedicated to the discovery and …

Patient Education Webcasts June 6, 2023

Cafecito con LLS: Hablemos de la salud mental

June 6, 2023

Family Support Groups - Upper Plains

News June 1, 2023

Subaru Partners with The Leukemia & Lymphoma Society for 8th Year to Share Warmth, Love and Relief with Patients Facing Cancer

Subaru of America, Inc. is renewing its partnership with The Leukemia & Lymphoma Society (LLS) during Subaru Loves to Care® month in June. Subaru will…

News May 31, 2023

FDA Approves New Bispecific Antibody for Non-Hodgkin Lymphoma Subtype

Epcoritamab gives patients with diffuse large B-cell lymphoma another treatment option.

Research May 25, 2023

Affimed Announces IND Clearance for a Phase 2 Clinical Trial Investigating AFM13 and AB-101 Combination Therapy

Heidelberg, Germany, May 23, 2023 – Affimed N.V. announced today that the U.S. Food and Drug Administration (FDA) has cleared its IND application for …

Patient Education Webcasts May 24, 2023

Spotlight on Chronic Lymphocytic Leukemia (CLL)

News May 23, 2023

Cancer Drug Shortages Greatly Affect Patients with Blood Cancer, Families Across the US

Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, releases statement noting that the LLS continues to advocate for solutions to keep…

News April 28, 2023